Enhanced bioavailability of a novel double-layered nano-liposomal curcumin (BNT-C060): a randomized, double-blind, clinical trial.

Researchers tested BNT-C060, a curcumin product carried in tiny fat-based bubbles. In a randomized, double-blind trial, people were assigned by chance, and neither participants nor researchers knew who received which product during testing. They measured bioavailability, meaning how much curcumin reached the bloodstream, and compared the new product with a control. The study reported that BNT-C060 increased curcumin levels in the blood. The available record does not give the participant count or show whether this improved symptoms, health, or lifespan.

What this means for you: This supports better absorption, not better health or longer life. Do not pay a premium for this product solely for longevity based on this study.